Novo Nordisk owner buys majority stake in Austrian life science tools company

Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk (NOVOb.CO), opens new tab, said on Wednesday it would buy a controlling stake of about 60% in Single Use Support, an Austria-based life science tools company.
It declined to give a precise value for the deal but a spokesperson said it would be a "high triple-digit million euros" amount.